METTL3/YTHDF2 m6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer

Haiyun Xie1, Jiangfeng Li1, Yufan Ying1

  • 1Department of Urology, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Insights

N6-Methyladenosine (m6A) RNA modification promotes bladder cancer (BCa) by degrading tumor suppressor mRNAs. Targeting the METTL3/YTHDF2 axis could offer new therapeutic strategies for BCa treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • N6-Methyladenosine (m6A) is the most common mRNA modification in eukaryotes.
  • m6A modification plays a role in various cancers, but its specific function in bladder cancer (BCa) remains unclear.

Purpose of the Study:

  • To investigate the role and mechanism of the m6A axis in bladder cancer progression.
  • To identify potential therapeutic targets for BCa.

Main Methods:

  • Depletion of METTL3 in vitro and in vivo.
  • Transcriptome sequencing.
  • m6A methylated RNA immunoprecipitation (MeRIP) and RIP assays.
  • Overexpression of SETD7 and KLF4.

Main Results:

  • METTL3 depletion inhibited BCa proliferation and metastasis.
  • The METTL3/YTHDF2 m6A axis was found to directly degrade the mRNAs of tumor suppressors SETD7 and KLF4.
  • Restoring SETD7 and KLF4 levels mimicked the effects of depleting the m6A axis.

Conclusions:

  • The METTL3/YTHDF2/SETD7/KLF4 m6A axis promotes bladder cancer progression.
  • This axis represents a potential therapeutic target for BCa.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K